ARCA Biopharma CEO Richard B. Brewer: An Interview With “The Pink Sheet” DAILY (Part 1 of 2)
This article was originally published in The Pink Sheet Daily
Executive Summary
Brewer speaks with the DAILY about ARCA’s product, a genetically targeted Phase III beta blocker abandoned by Bristol-Myers Squibb.